We are live on ! Find out more
Quantbot Technologies

Quantbot Technologies Portfolio holdings

AUM $2.78B Turnover 51.46%
1-Year Est. Return 9.9%
 

Quantbot Technologies runs computer-driven trading strategies, buying and selling stocks long and short and holding positions from a few seconds to a few days. The firm was founded in 2009 and also trades options, swaps and futures. It is hired to manage money for private funds, whose investors are institutional investors, high net worth individuals and employees. Paul White is its president and chief executive, and Ashar Mahboob is its chief investment officer.

This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
+9.9%
3 Year Est. Return
+36.77%
5 Year Est. Return
+5.57%
10 Year Est. Return
+35.66%
AUM
$1.43B
AUM Growth
-$39.5M
Cap. Flow
-$50M
Cap. Flow %
-3.5%
Top 10 Hldgs %
8.51%
Holding
1,725
New
560
Increased
312
Reduced
348
Closed
498
Avg Time Held
0.3 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$16.3M
2
PYPL icon
PayPal
PYPL
+$15.7M
3
WMT icon
Walmart
WMT
+$13.8M
4
ROP icon
Roper Technologies
ROP
+$11.5M
5
PEP icon
PepsiCo
PEP
+$10.4M

Top Sells

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$16.4M
2
AVGO icon
Broadcom
AVGO
+$16M
3
AABA
Altaba Inc
AABA
+$13.9M
4
HON icon
Honeywell
HON
+$13.1M
5
PGR icon
Progressive
PGR
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 15.51%
2 Consumer Discretionary 14.07%
3 Financials 13.87%
4 Industrials 12.94%
5 Healthcare 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CLLS icon
876
Cellectis
CLLS
$104M
$99K 0.01%
3,528
+3,076
+681% +$88.4K
2018 Q1
2 quarters
ENTA icon
877
Enanta Pharmaceuticals
ENTA
$240M
$99K 0.01%
+1,170
New +$117K
2018 Q3
0 quarters
ESPR icon
878
DELISTED
Esperion Therapeutics
ESPR
$99K 0.01%
+2,250
New +$103K
2018 Q3
0 quarters
IOSP icon
879
Innospec
IOSP
$1.94B
$99K 0.01%
+1,298
New +$101K
2018 Q3
0 quarters
NICE icon
880
Nice
NICE
$5.15B
$99K 0.01%
868
+201
+30% +$22.5K
2018 Q1
2 quarters
AGX icon
881
Argan
AGX
$4.26B
$96K 0.01%
2,248
+16
+0.7% +$648
2017 Q2
5 quarters
DLTH icon
882
Duluth Holdings
DLTH
$152M
$96K 0.01%
+3,053
New +$83.5K
2018 Q3
0 quarters
ITRI icon
883
Itron
ITRI
$4.3B
$96K 0.01%
1,496
-5,401
-78% -$341K
2018 Q2
1 quarter
PBR.A icon
884
Petrobras Class A
PBR.A
$94.5B
$96K 0.01%
9,264
+6,623
+251% +$64.3K
2017 Q4
3 quarters
TDW icon
885
Tidewater
TDW
$3.63B
$96K 0.01%
+3,093
New +$97.4K
2018 Q3
0 quarters
CRAY
886
DELISTED
Cray
CRAY
$96K 0.01%
4,511
-371
-8% -$8.55K
2018 Q2
1 quarter
EFSC icon
887
Enterprise Financial Services
EFSC
$2.13B
$95K 0.01%
+1,803
New +$100K
2018 Q3
0 quarters
VCEL icon
888
Vericel
VCEL
$2.99B
$95K 0.01%
6,749
+6,300
+1,403% +$73.9K
2018 Q2
1 quarter
TLND
889
DELISTED
Talend
TLND
$95K 0.01%
1,373
-291
-17% -$18.3K
2017 Q4
3 quarters
NCI icon
890
DELISTED
Navigant Consulting
NCI
$95K 0.01%
+4,142
New +$95.9K
2018 Q3
0 quarters
WFT
891
DELISTED
Weatherford International
WFT
$95K 0.01%
35,300
-15,196
-30% -$44.6K
2018 Q1
2 quarters
CNNE icon
892
Cannae Holdings
CNNE
$686M
$94K 0.01%
4,495
-10,906
-71% -$213K
2018 Q2
1 quarter
FLO icon
893
Flowers Foods
FLO
$1.11B
$94K 0.01%
+5,089
New +$103K
2018 Q3
0 quarters
EPZM
894
DELISTED
Epizyme
EPZM
$94K 0.01%
8,894
+922
+12% +$10.5K
2018 Q1
2 quarters
DRNA
895
DELISTED
Dicerna Pharmaceuticals
DRNA
$94K 0.01%
6,193
-6,614
-52% -$96.3K
2018 Q2
1 quarter
BPFH
896
DELISTED
Boston Private Financial Holdings
BPFH
$94K 0.01%
6,958
-2,652
-28% -$38.8K
2017 Q3
4 quarters
ATTU
897
DELISTED
Attunity
ATTU
$94K 0.01%
+5,028
New +$85.4K
2018 Q3
0 quarters
DOC icon
898
DELISTED
Physicians Realty Trust
DOC
$94K 0.01%
5,598
+70
+1% +$1.16K
2018 Q2
1 quarter
CNO icon
899
CNO Financial Group
CNO
$5.14B
$92K 0.01%
+4,381
New +$91.9K
2018 Q3
0 quarters
LKFT icon
900
Lakefront Biotherapeutics American Depositary Shares
LKFT
$2.25B
$92K 0.01%
820
-743
-48% -$78.5K
2017 Q3
4 quarters

Similar funds

Quantbot Technologies's Q3 2018 Portfolio in Review

As of Q3 2018, Quantbot Technologies held 1,725 positions worth $1.43B, down 2.7% from $1.47B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Quantbot Technologies withdrew a net $50M in Q3 2018, closing 498 positions and reducing 348 holdings. Its most notable exit was Caterpillar, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Quantbot Technologies opened a new position in S&P Global worth $15.5M.

  • Quantbot Technologies's largest Q3 2018 buy was S&P Global: 79,131 shares worth $15.5M.
  • Quantbot Technologies added most to Roper Technologies in Q3 2018, an estimated $11.5M increase.
  • Quantbot Technologies's biggest Q3 2018 reduction was Progressive, cutting an estimated $12.9M.
  • Quantbot Technologies fully exited Caterpillar in Q3 2018, selling an estimated $16.4M.
  • Quantbot Technologies's ten largest holdings make up 8.5% of its $1.43B portfolio in Q3 2018.
  • Quantbot Technologies opened 560 new positions and closed 498 in Q3 2018.
  • Quantbot Technologies's portfolio value fell 2.7% quarter-over-quarter to $1.43B.

Based on Quantbot Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.